Welcome to your medical weight loss journey with compounded Tirzepatide or Semaglutide. This guide explains how to safely inject at home. Whether you're new or adjusting your dose, we’re here to make the process simple and clear.
Pick a spot that feels right and follow these simple tips:
Tip: Rotate your injection site each week to avoid skin irritation.
Performing an injection correctly is important for your safety, comfort, and best results. Follow these simple steps carefully to ensure proper technique.
Wash your hands. Use an alcohol wipe to clean the injection site.
Hold the syringe like a dart. Pinch your skin gently to create a firm surface.
Use a quick motion to insert the needle straight in. It’s more comfortable that way.
Push the plunger down with your index finger until all medicine is gone.
Pull the needle out the same way it went in.
Use a sharps container for the needle. Store unused syringes in the fridge.
Here’s a quick look at how syringe units convert to milliliters:
The information provided on this website is intended for general reference only and may include examples of commonly used dosages or formulations. Please note that specific units, concentrations, or protocols may vary depending on your pharmacy's formulation and dispensing practices. Always follow the exact dosing instructions provided with your prescription or directly by your pharmacy or healthcare provider. This content is not intended to replace personalized medical guidance or instructions provided by licensed professionals.
SpadeRx provides access to compounded medications for qualified patients. Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects compared to FDA-approved products. A licensed provider will perform a telehealth Good Faith Exam (GFE) to determine patient eligibility before any prescription is issued. Not all patients are candidates, and individual results may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus®, Ozempic®, Wegovy®) and tirzepatide (Zepbound®, Mounjaro®), respectively. These manufacturers do not supply their medications for compounding.
Have A Question?